Results 91 to 100 of about 11,489 (193)

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes

Virology, 2016
In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20-30% plaque-forming virions in fully permissive cell cultures.
Anna-Theresa Lülf, Astrid Freudenstein, Lisa Marr, Gerd Sutter, Asisa Volz   +4 more
openaire   +3 more sources

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro

Vaccine, 2000
The immunogenicity of recombinant modified vaccinia Ankara, a highly attenuated vaccinia virus, expressing influenza nucleoprotein (MVA-NP) and HIV-1 gag (MVA-gag) was investigated. Restimulation of peripheral blood lymphocytes of healthy subjects with MVA-NP led to expansion of CTL with specificity for known NP epitopes. These CTL efficiently lysed NP
Dorrell, L., O'Callaghan, C. A., Britton, W., Hambleton, S., McMichael, A., Smith, G. L., Rowland-Jones, S., Blanchard, T. J.   +7 more
openaire   +5 more sources

Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen [PDF]

, 2000
Todd M. Allen, Thorsten U. Vogel, Deborah H. Fuller, Bianca R. Mothé, Susan R. Steffen, Jon E. Boyson, Tim Shipley, Jim Fuller, Tomáš Hanke, Alessandro Sette, John D. Altman, Bernard Moss, Andrew J. McMichael, David I. Watkins   +13 more
openalex   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Recombinant Modified Vaccinia Virus Ankara Expressing the Surface gp120 of Simian Immunodeficiency Virus (SIV) Primes for a Rapid Neutralizing Antibody Response to SIV Infection in Macaques [PDF]

, 2000
Ilnour Ourmanov, Miroslawa Bilska, Vanessa M. Hirsch, David C. Montefiori   +3 more
openalex   +1 more source

Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV [PDF]

, 2000
Ilnour Ourmanov, Charles R. Brown, Bernard Moss, Miles W. Carroll, Linda S. Wyatt, Liuobov Pletneva, Simoy Goldstein, David Venzon, Vanessa M. Hirsch   +8 more
openalex   +1 more source

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2 [PDF]

, 2001
Katrina T. Trevor, Evan M. Hersh, Jacquie Brailey, Jean-Marc Balloul, Bruce Acres   +4 more
openalex   +1 more source

Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. [PDF]

J Immunother Cancer, 2023
Bella Á, Arrizabalaga L, Di Trani CA, Gonzalez-Gomariz J, Gomar C, Russo-Cabrera JS, Olivera I, Cirella A, Fernandez-Sendin M, Alvarez M, Teijeira A, Atay C, Medina-Echeverz J, Hinterberger M, Hochrein H, Melero I, Berraondo P, Aranda F.   +17 more
europepmc   +1 more source

Prime‐Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Virus–2 Glycoprotein D Elicits Greater Specific Antibody and Cytokine Responses than DNA Vaccine Alone [PDF]

, 2002
Clement A. Meseda, Karen L. Elkins, Michael Merchlinsky, Jerry P. Weir   +3 more
openalex   +1 more source

Recombinant viruses as tools to induce protective cellular immunity against infectious diseases [PDF]

, 2010
Infections by intracellular pathogens such as viruses, some bacteria and many parasites, are cleared in most cases after activation of specific T cellular immune responses that recognize foreign antigens and eliminate infected cells.
Alexandre Vieira Machado, Braulia Costa Caetano, Carolina Damas Rocha, Oscar Bruña-Romero   +3 more
core   +2 more sources